Answers are grounded in this paper and cite their sources.
We aim to evaluate the indication and use of genomic signatures in breast cancer patients and outcomes who in patients undergoing adjuvant chemotherapy or not.
No takes yet. Share an insight, caveat, or question.
Vieira et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: